1. Towards a dependable data set of structures for l‐asparaginase research.
- Author
-
Wlodawer, Alexander, Dauter, Zbigniew, Lubkowski, Jacek, Loch, Joanna I., Brzezinski, Dariusz, Gilski, Miroslaw, and Jaskolski, Mariusz
- Subjects
- *
BIOMACROMOLECULES , *CHEMICAL modification of proteins , *BACTERIAL proteins , *DRUG discovery , *BANKING industry - Abstract
The Protein Data Bank (PDB) includes a carefully curated treasury of experimentally derived structural data on biological macromolecules and their various complexes. Such information is fundamental for a multitude of projects that involve large‐scale data mining and/or detailed evaluation of individual structures of importance to chemistry, biology and, most of all, to medicine, where it provides the foundation for structure‐based drug discovery. However, despite extensive validation mechanisms, it is almost inevitable that among the ∼215 000 entries there will occasionally be suboptimal or incorrect structure models. It is thus vital to apply careful verification procedures to those segments of the PDB that are of direct medicinal interest. Here, such an analysis was carried out for crystallographic models of l‐asparaginases, enzymes that include approved drugs for the treatment of certain types of leukemia. The focus was on the adherence of the atomic coordinates to the rules of stereochemistry and their agreement with the experimental electron‐density maps. Whereas the current clinical application of l‐asparaginases is limited to two bacterial proteins and their chemical modifications, the field of investigations of such enzymes has expanded tremendously in recent years with the discovery of three entirely different structural classes and with numerous reports, not always quite reliable, of the anticancer properties of l‐asparaginases of different origins. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF